Location History:
- Raleigh, NC (US) (2020)
- Atlanta, GA (US) (2020)
- Durham, NC (US) (2017 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: **David G. Ousterout: Pioneering Innovations in Genetic Engineering**
Introduction
David G. Ousterout, an innovative inventor located in Raleigh, NC, has made significant contributions to the field of genetic engineering. With an impressive portfolio of five patents, Ousterout is recognized for his work in advancing gene editing technologies that have the potential to revolutionize medical treatments.
Latest Patents
Ousterout’s latest patents showcase his expertise in genetic correction and gene editing. His first noteworthy patent, titled "Genetic correction of mutated genes," discloses transcription activator-like effector nuclease (TALEN)-related compositions and methods aimed at correcting mutant genes. This innovation holds promise for treating genetic disorders by targeting and repairing faulty genes.
Another significant contribution is his patent on "RNA-guided gene editing and gene regulation." This patent reveals compositions and methods based on the CRISPR/Cas9 system, which can alter gene expression and facilitate genome engineering. Particularly, these methods apply to muscle tissues, including skeletal and cardiac muscles, paving the way for enhanced therapeutic strategies.
Career Highlights
David G. Ousterout is currently affiliated with Duke University, where he continues to push the boundaries of genetic research. His academic and professional journey has positioned him among the leading innovators in genetic engineering, as evidenced by his multiple patents.
Collaborations
Throughout his career, Ousterout has collaborated with accomplished scientists, including Charles A. Gersbach and Isaac B. Hilton. These partnerships have enabled him to broaden the scope of his research and maximize the impact of his findings on the scientific community and beyond.
Conclusion
In summary, David G. Ousterout's innovative work in genetic engineering through his patents illustrates the profound possibilities that lie within gene editing technologies. His contributions not only strengthen the scientific understanding of genetic mutations but also open new avenues for therapeutic interventions. As he continues his work at Duke University, the impact of his inventions will likely resonate within the fields of medicine and biotechnology for years to come.